Prospective follow up after omalizumab discontinuation in a cohort of children with severe asthma-Reference-Cited by-同舟云学术

Prospective follow up after omalizumab discontinuation in a cohort of children with severe asthma

Published:2023-05-24 Issue:8 Volume:58 Page:2424-2426
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Ferraro Valentina Agnese¹,Licari Amelia²³^ORCID,Volpini Alessandro⁴^ORCID,Fenu Grazia⁵,Patria Maria Francesca⁶,Seminara Manuela⁷,Spada Elena⁸,Rusconi Franca⁹^ORCID

Affiliation:

1. Women's and Children's Health Department University of Padua Padua Italy

2. Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences University of Pavia Pavia Italy

3. Pediatric Clinic Fondazione IRCCS Policlinico San Matteo Pavia Italy

4. Pediatric Unit, Department of Mother and Child Health Salesi Children's Hospital Ancona Italy

5. Pediatric Pulmonary Unit “Anna Meyer” IRCCS Pediatric University‐Hospital Florence Italy

6. Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milan Italy

7. Pediatric Asthma and Cough Centre, Istituti Ospedalieri Bergamaschi University and Research Hospitals Bergamo Italy

8. Laboratorio Della Conoscenza Carlo Corchia, APS Florence Italy

9. Department of Mother and Child Health Azienda USL Toscana Nord Ovest Pisa Italy

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.26500

Reference7 articles.

1. Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience

2. Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients

3. Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma

4. Omalizumab discontinuation in children with severe allergic asthma: An observational real‐life study

5. Four-year follow-up in children with moderate/severe uncontrolled asthma after withdrawal of a 1-year omalizumab treatment

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolution of Scientific Knowledge in Childhood Asthma over Time: A Surprising History;Children;2024-02-18

2. Defining response to therapy with biologics in severe asthma: from global evaluation to super response and remission;Expert Review of Respiratory Medicine;2023-06-03